While the future of microbiome drug advancements looks bright, young startups may struggle to gain funding as investors aim to mitigate risk in the face of a wider unstable landscape.
The impact of COVID-19 on retail and food-to-go channels has challenged many food businesses. Yet challenger brands and start-ups with an agile mindset can use the crisis to their advantage, say a panel of experts.